Similar Posts
- Business of Medicine | Current Controversies | Global Public Health Institutions | Pharma Corrupt Influence | Propaganda -- Censorship | Public Policy
America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?
Part II. What Do We Get for All That Money? A preventable epidemic of injury and death from prescription drugs; FDA’s contribution to the epidemic; Big Pharma’s business model: manufactured myths, propaganda and a hidden agenda;
Drug Test Loopholes
Subject: Drug Test Loopholes Date: Mon, 7 Oct 2002 09:08:50 -0400 The medical, legal and ethical repercussions of the use of untested medical products–including the smallpox vaccine– have not been publicly debated. Below is a column by Meryl Nass, MD, that appeared online at Redflagsweekly.com in August, addressing the inadequate…
Treating children as young as 4 for bipolar – WSJ
Treating children as young as 4 for bipolar – WSJ Thu, 26 May 2005 A report in The Wall Street Journal should raise serious concerns about the legitimacy of psychiatric diagnosing and drug prescribing for children. The Journal reports that close to 20,000 US children are being diagnosed with bi-polar…
Antidepressant Controversy: Media Conflicts of Interest – New York Times
Antidepressant Controversy: Media Conflicts of Interest – New York Times Thu, 25 Mar 2004 FDA’s advisory warning about antidepressant drugs received wide press coverage nationally. But few in the national media mentioned conflicts of interest as the obstacle to disclosure of evidence showing these drugs’ adverse effects. Among the few…
Bill Moyers: the Real Show…Congressional hearing was abruptly cancelled
Bill Moyers: the Real Show…Congressional hearing was abruptly cancelled Tue, 27 Jul 2004 Congressman Greenwoods’ retirement statement indicates that he had negotiated his contract with Biotechnology Industry Org–a company that represents the very industry he was in the middle of investigating–on Tuesday. http://www.house.gov/greenwood/press_releases/2004/pr040722.html Tuesday was the precise day that Greenwood…
Patient vs. Portfolio: ImClone – Salon
Patient vs. Portfolio: ImClone_Salon December 9, 2002 Salon.com looks at how conflicts of interest impact on patients who are recruited to serve as subjects of clinical drug trials. “Patients affected by the ImClone scandal have been lost in the media’s rush to cover the tale of Martha Stewart and other…